RMC No. 124-2022: VAT-Exempt Medicines Updated for Cancer, Tuberculosis, Mental Illness, Diabetes, and Hypertension Under CREATE
RMC No. 124-2022 updates VAT-exempt medicines under CREATE for cancer, tuberculosis, mental illness, diabetes, and hypertension based on FDA publication. Businesses selling, importing, prescribing, dispensing, accounting for, or claiming VAT treatment on covered medicines must check the updated VAT-exempt medicine list immediately because the exemption applies based on the date the Food and Drug Administration […]